DrugsControl Media Services
DrugsControl.org

News Detail

Delhi HC reinstates Injunction stopping sale of Zydus’ Sigrima (29-10-2024)

New Delhi, 29 Oct 2024: The Division Bench of Delhi High Court, on October 16, 2024, reinstated the injunction preventing Zydus Lifesciences from manufacturing, selling, or marketing its breast cancer drug Sigrima, a biosimilar of Roche’s Pertuzumab (Perjeta). The decision,......
View Details

Source : Express Pharma
cancer drug Delhi High Court Pertuzumab Roche Sigrima Zydus

Related News